Back
  1. Home
  2. Profile of Markus OLLERT (Unilu)
Profil

OLLERT Markus

University of Luxembourg

Main Referenced Co-authors
HE, Feng  (7)
KRÜGER, Rejko  (7)
WILMES, Paul  (7)
FAGHERAZZI, Guy  (6)
Zeng, Ni (6)
Main Referenced Keywords
COVID-19 (8); SARS-CoV-2 (8); Humans (5); Animals (2); Antibodies, Neutralizing (2);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) (2)
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) (2)
LIH - Luxembourg Institute of Health (1)
Luxembourg Centre for Systems Biomedicine (LCSB): Eco-Systems Biology (Wilmes Group) (1)
Main Referenced Disciplines
Immunology & infectious disease (7)
Neurology (3)
Genetics & genetic processes (2)
Microbiology (2)
Endocrinology, metabolism & nutrition (1)

Publications (total 15)

The most downloaded
80 downloads
Capelle, C., Cire, S., Hansen, M., Pavelka, L., Hedin, F., Konstantinou, M., Revets, D., Tslaf, V., Marques, T., Baron, A., Domingues, O., Zeng, N., May, P., Cosma, A., Balling, R., Krüger, R., Ollert, M., & He, F. (2022). Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51989. doi:10.21203/rs.3.rs-1834770/v1 https://hdl.handle.net/10993/51989

The most cited

59 citations (Scopus®)

Wilmes, P., Zimmer, J., Schulz, J., Glod, F., Veiber, L., Mombaerts, L., Rodrigues, B., Aalto, A., Pastore, J., Snoeck, C. J., Ollert, M., Fagherazzi, G., Mossong, J., Goncalves, J., Skupin, A., & Nehrbass, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056 https://hdl.handle.net/10993/51820

Capelle, C. M., Ciré, S., Hedin, F., HANSEN, M., PAVELKA, L., GRZYB, K., KYRIAKIS, D., Hunewald, O., Konstantinou, M., Revets, D., TSLAF, V., Marques, T. M., GOMES, C., BARON, A., Domingues, O., Gomez, M., Zeng, N., BETSOU, F., MAY, P., ... Hefeng, F. Q. (20 November 2023). Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nature Communications, 14 (1), 7461. doi:10.1038/s41467-023-43053-0
Peer Reviewed verified by ORBi

Santos da Silva, E., Servais, J.-Y., Kohnen, M., Arendt, V., Staub, T., The Con-Vince Consortium, The CoVaLux Consortium, Krüger, R., FAGHERAZZI, G., WILMES, P., Hübschen, J. M., OLLERT, M., Perez-Bercoff, D., & Seguin-Devaux, C. (06 October 2023). Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern. International Journal of Molecular Sciences, 24 (19), 14965. doi:10.3390/ijms241914965
Peer Reviewed verified by ORBi

de Nies, L., Galata, V., Martin-Gallausiaux, C., Despotovic, M., Busi, S. B., Snoeck, C. J., Delacour, L., Budagavi, D. P., Laczny, C. C., Habier, J., Lupu, P.-C., Halder, R., Fritz, J. V., Marques, T., Sandt, E., O'Sullivan, M. P., Ghosh, S., Satagopam, V., Consortium, C.-V., ... Wilmes, P. (09 March 2023). Altered infective competence of the human gut microbiome in COVID-19. Microbiome, 11 (1), 46. doi:10.1186/s40168-023-01472-7
Peer Reviewed verified by ORBi

Fischer, A., Badier, N., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Benoy, C., OLLERT, M., & FAGHERAZZI, G. (30 November 2022). Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. International Journal of Environmental Research and Public Health, 19 (23), 16018. doi:10.3390/ijerph192316018
Peer Reviewed verified by ORBi

Meyrath, M., Szpakowska, M., Plesseria, J.-M., Domingues, O., Langlet, J., Weber, B., Krüger, R., Ollert, M., & Chevigné, A. (09 September 2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology, 675, 351-381. doi:10.1016/bs.mie.2022.07.015
Peer Reviewed verified by ORBi

Fischer, A., Zhang, L., Elbéji, A., WILMES, P., Oustric, P., Staub, T., Nazarov, P. V., OLLERT, M., & FAGHERAZZI, G. (August 2022). Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infectious Diseases, 9 (8), 397. doi:10.1093/ofid/ofac397
Peer Reviewed verified by ORBi

Capelle, C., Cire, S., Hansen, M., Pavelka, L., Hedin, F., Konstantinou, M., Revets, D., Tslaf, V., Marques, T., Baron, A., Domingues, O., Zeng, N., May, P., Cosma, A., Balling, R., Krüger, R., Ollert, M., & He, F. (2022). Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51989. doi:10.21203/rs.3.rs-1834770/v1

Danileviciute, E., Zeng, N., Capelle, C. M., Paczia, N., Gillespie, M. A., Kurniawan, H., Benzarti, M., Merz, M. P., Coowar, D., Fritah, S., Vogt Weisenhorn, D. M., Gomez Giro, G., Grusdat, M., Baron, A., Guerin, C., Franchina, D. G., Léonard, C., Domingues, O., Delhalle, S., ... He, F. (26 May 2022). PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains T(reg) homeostasis during ageing. Nature Metabolism, 4 (5), 589-607. doi:10.1038/s42255-022-00576-y
Peer Reviewed verified by ORBi

Capelle, C. M., Ciré, S., Domingues, O., Ernens, I., Hedin, F., Fischer, A., Snoeck, C. J., Ammerlaan, W., Konstantinou, M., Grzyb, K., Skupin, A., Carty, C. L., Hilger, C., Gilson, G., Celebic, A., Wilmes, P., Del Sol, A., Kaplan, I. M., Betsou, F., ... He, F. (2022). Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Reports Medicine, 3 (4), 100600. doi:10.1016/j.xcrm.2022.100600
Peer reviewed

Capelle, C. M., Chen, A., Zeng, N., Baron, A., Grzyb, K., Arns, T., Skupin, A., Ollert, M., & He, F. (2022). Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1. Immunology, 165 (4), 428--444. doi:10.1111/imm.13448
Peer Reviewed verified by ORBi

Zeng, N.* , Capelle, C. M.* , Baron, A., Kobayashi, T., Cire, S., Tslaf, V., Leonard, C., Coowar, D., Koseki, H., Westendorf, A. M., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2022). DJ‐1 depletion prevents immunoaging in T‐cell compartments. EMBO Reports, 23 (3). doi:10.15252/embr.202153302
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Zeng, N., Capelle, C., Baron, A., Cire, S., Leonard, C., Coowar, D., Koseki, H., Westendorf, A., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2021). DJ-1 depletion slows down immunoaging in T-cell compartments. bioRxiv. doi:10.1101/2021.05.21.445139

Holuka, C., Snoeck, C. J., Mériaux, S. B., Ollert, M., Krüger, R., Turner, J., & The Con-Vince Consortium. (2021). Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity. Journal of Clinical Medicine, 10 (10). doi:10.3390/jcm10102159
Peer Reviewed verified by ORBi

Wilmes, P., Zimmer, J., Schulz, J., Glod, F., Veiber, L., Mombaerts, L., Rodrigues, B., Aalto, A., Pastore, J., Snoeck, C. J., Ollert, M., Fagherazzi, G., Mossong, J., Goncalves, J., Skupin, A., & Nehrbass, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056
Peer Reviewed verified by ORBi

CZOLK, R. M., Klueber, J., Sørensen, M., WILMES, P., Codreanu-Morel, F., Skov, P. S., HILGER, C., Bindslev-Jensen, C., OLLERT, M., & KUEHN, A. (2020). IgE-Mediated Peanut Allergy: Current and Novel Predictive Biomarkers for Clinical Phenotypes Using Multi-Omics Approaches. Frontiers in Immunology, 11, 594350. doi:10.3389/fimmu.2020.594350
Peer Reviewed verified by ORBi

Contact ORBilu